{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:53:04Z","timestamp":1776664384439,"version":"3.51.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study aims to investigate the predictive value of the fibrinogen-to-high-density lipoprotein cholesterol ratio (FHR) in relation to sub-clinical diabetic peripheral neuropathy (sDPN) in individuals diagnosed with type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cohort of 281 patients with T2DM was admitted to the Neurology Department of Jiangxi Provincial People\u2019s Hospital between January and December 2023. Within this population, 148 patients were diagnosed with sDPN. The clinical profiles, inflammatory biomarkers, and nerve conduction velocities or current perception thresholds (CPTs) were compared between the two distinct groups. A logistic regression analysis was performed to identify the risk factors for sDPN. The predictive performance of each factor was assessed using a receiver operating characteristic (ROC) curve analysis. The FHR was compared among three groups, which were based on the severity of peripheral neuropathy (PN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with sDPN exhibited significantly elevated levels of fibrinogen (FIB), fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), the monocyte-to-lymphocyte ratio (MLR), and the platelet-to-lymphocyte ratio (PLR), along with diminished high-density lipoprotein cholesterol (HDL-C) levels, compared to patients without sDPN. Univariate and multivariate logistic regression analyses indicated that age, FIB levels, HbA1c, HDL-C, and MLR were significant risk factors that contributed to the onset of sDPN in T2DM patients. The ROC curve analysis indicated that the FHR had an area under the curve (AUC) of 65%. The optimal cutoff value for the FHR was 2.65, exhibiting a specificity of 62.4% and a sensitivity of 63.5%. The composite model incorporating the FHR demonstrated superior reclassification performance (net reclassification improvement (NRI)\u202f=\u202f0.416,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001, 95% CI 0.180\u20130.650) and integrated discrimination improvement (IDI\u202f=\u202f0.053,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001, 95% CI 0.001\u20130.015) compared to the basic model (age +HbA1c\u202f+\u202fMLR). Nonparametric test analysis showed significant differences in the FHR among the three groups. The more severe the PN, the higher the FHR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The FHR may serve as a valuable early diagnostic marker for sDPN in T2DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1772503","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:24:02Z","timestamp":1776662642000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of the fibrinogen-to-high-density lipoprotein cholesterol ratio for sub-clinical diabetic peripheral neuropathy in type 2 diabetes mellitus"],"prefix":"10.3389","volume":"18","author":[{"given":"Yanmei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College","place":["Nanchang, Jiangxi, China"]},{"name":"Department of Neurology, National Regional Center for Neurological Diseases, Xiangya Hospital, Central South University","place":["Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College","place":["Nanchang, Jiangxi, China"]},{"name":"Department of Neurology, National Regional Center for Neurological Diseases, Xiangya Hospital, Central South University","place":["Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College","place":["Nanchang, Jiangxi, China"]},{"name":"Department of Neurology, National Regional Center for Neurological Diseases, Xiangya Hospital, Central South University","place":["Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College","place":["Nanchang, Jiangxi, China"]},{"name":"Department of Neurology, National Regional Center for Neurological Diseases, Xiangya Hospital, Central South University","place":["Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyao","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College","place":["Nanchang, Jiangxi, China"]},{"name":"Department of Neurology, National Regional Center for Neurological Diseases, Xiangya Hospital, Central South University","place":["Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College","place":["Nanchang, Jiangxi, China"]},{"name":"Department of Neurology, National Regional Center for Neurological Diseases, Xiangya Hospital, Central South University","place":["Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College","place":["Nanchang, Jiangxi, China"]},{"name":"Department of Neurology, National Regional Center for Neurological Diseases, Xiangya Hospital, Central South University","place":["Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/2047487319848214","article-title":"HDL: fact, fiction, or function? HDL cholesterol and cardiovascular risk","volume":"28","author":"Allard-Ratick","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref2","first-page":"217","article-title":"Neuropathy and other risk factors for lower extremity amputation in people with diabetes using a clinical data repository system","volume":"47","author":"Alothman","year":"2018","journal-title":"J. Allied Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.2147\/DMSO.S427510","article-title":"Correlation between fibrinogen\/albumin and diabetic peripheral neuropathy","volume":"16","author":"Ban","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/1076029615594002","article-title":"Association of Monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation","volume":"22","author":"Canpolat","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2147\/DMSO.S407391","article-title":"The ratio of fibrinogen to albumin is related to the occurrence of retinopathy in type 2 diabetic patients","volume":"16","author":"Chen","year":"2023","journal-title":"Diabetes Metab Syndr Obes."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"934020","DOI":"10.3389\/fendo.2022.934020","article-title":"Determinants of diabetic peripheral neuropathy and their clinical significance: a retrospective cohort study","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2337\/dc19-2277","article-title":"Metabolic factors, lifestyle habits, and possible polyneuropathy in early type 2 diabetes: a nationwide study of 5,249 patients in the Danish Centre for Strategic Research in type 2 diabetes (DD2) cohort","volume":"43","author":"Christensen","year":"2020","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/dmrr.1226","article-title":"Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity","volume":"27","author":"Dyck","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S1474-4422(22)00188-0","article-title":"Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments","volume":"21","author":"Elafros","year":"2022","journal-title":"The Lancet Neurology."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pcd.2022.11.011","article-title":"Glycemic profile variability: an independent risk factor for diabetic neuropathy in patients with type 2 diabetes","volume":"17","author":"Firouzabadi","year":"2023","journal-title":"Prim. Care Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","article-title":"Schwann cell interactions with axons and microvessels in diabetic neuropathy","volume":"13","author":"Gon\u00e7alves","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.actbio.2016.09.024","article-title":"Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen","volume":"47","author":"Hsieh","year":"2017","journal-title":"Acta Biomater."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1111\/bph.13743","article-title":"Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism","volume":"174","author":"Iqbal","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1128069","DOI":"10.3389\/fpubh.2023.1128069","article-title":"Development and validation of a risk prediction model for early diabetic peripheral neuropathy based on a systematic review and meta-analysis","volume":"11","author":"Liu","year":"2023","journal-title":"Front. Public Health"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/17446651.2023.2279533","article-title":"The vascular complications of diabetes: a review of their management, pathogenesis, and prevention","volume":"19","author":"Meir","year":"2024","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jdi.13679","article-title":"Diversity of pathophysiology in type 2 diabetes shown by islet pathology","volume":"13","author":"Mizukami","year":"2022","journal-title":"J. Diabetes Investig."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2337\/dc12-0306","article-title":"Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study","volume":"35","author":"Morton","year":"2012","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00125-014-3461-z","article-title":"The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy","volume":"58","author":"\u00d8stergaard","year":"2015","journal-title":"Diabetologia"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13813455.2020.1797106","article-title":"Role of advanced glycation end products and insulin resistance in diabetic nephropathy","volume":"129","author":"Parwani","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","article-title":"Inflammation as a therapeutic target for diabetic neuropathies","volume":"16","author":"Pop-Busui","year":"2016","journal-title":"Curr. Diabetes Rep."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"13136","DOI":"10.1038\/s41598-023-40429-6","article-title":"Prognostic value of monocyte-to-lymphocyte ratio for 90-day all-cause mortality in type 2 diabetes mellitus patients with chronic kidney disease","volume":"13","author":"Qiu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/ars.2021.0155","article-title":"A role for fatty acids in peripheral neuropathy associated with type 2 diabetes and prediabetes","volume":"37","author":"Rumora","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/ijms21020601","article-title":"The role and function of HDL in patients with chronic kidney disease and the risk of cardiovascular disease","volume":"21","author":"Rysz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1523\/JNEUROSCI.1852-20.2021","article-title":"High dietary fat consumption impairs axonal mitochondrial function in vivo","volume":"41","author":"Sajic","year":"2021","journal-title":"J. Neurosci."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-015-0123-1","article-title":"The role of fatty acids in insulin resistance","volume":"14","author":"Sears","year":"2015","journal-title":"Lipids Health Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/ijms22010062","article-title":"Blood\u2013nerve barrier (BNB) pathology in diabetic peripheral neuropathy and in vitro human BNB model","volume":"22","author":"Takeshita","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/dmrr.2239","article-title":"Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy","volume":"28","author":"Tesfaye","year":"2012","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pmr.2007.10.010","article-title":"The spectrum of diabetic neuropathies","volume":"19","author":"Tracy","year":"2008","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.1074\/jbc.275.15.11278","article-title":"High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae","volume":"275","author":"Uittenbogaard","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"10641","DOI":"10.3390\/ijms231810641","article-title":"Circulating biomarkers of endothelial dysfunction and inflammation in predicting clinical outcomes in diabetic patients with critical limb ischemia","volume":"23","author":"Vieceli Dalla Sega","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e3702","DOI":"10.1002\/dmrr.3702","article-title":"Prevalence and risk factors of diabetic peripheral neuropathy: a population-based cross-sectional study in China","volume":"39","author":"Wang","year":"2023","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12933-022-01477-w","article-title":"High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e57427","DOI":"10.1371\/journal.pone.0057427","article-title":"High energy diets-induced metabolic and prediabetic painful polyneuropathy in rats","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1210\/clinem\/dgac651","article-title":"Altered intrinsic brain activity related to neurologic and motor dysfunction in diabetic peripheral neuropathy patients","volume":"108","author":"Xin","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2217\/fon-2018-0376","article-title":"Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2019","journal-title":"Future Oncol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","article-title":"Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment","volume":"14","author":"Zhu","year":"2024","journal-title":"Front. Endocrinol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13098-021-00777-7","article-title":"Fibrinogen function indexes are potential biomarkers of diabetic peripheral neuropathy","volume":"14","author":"Zhuang","year":"2022","journal-title":"Diabetol. Metab. Syndr."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1772503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:24:03Z","timestamp":1776662643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1772503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":38,"alternative-id":["10.3389\/fnagi.2026.1772503"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1772503","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1772503"}}